About
RNA Therapeutics
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapySan Diego & Southern California
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
627
By Phase
PHASE2: 2PHASE3: 1PHASE1: 2PHASE1/PHASE2: 2
By Status
RECRUITING: 4NOT_YET_RECRUITING: 3
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06990269Lead Sponsor
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
PHASE2Not yet recruiting
240 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2027
NCT06960213Lead Sponsor
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
PHASE3Recruiting
90 participants
Started: Aug 28, 2025 · Completed: Dec 31, 2026
NCT06989359Lead Sponsor
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
PHASE2Not yet recruiting
30 participants
Started: Jul 31, 2025 · Completed: Jul 31, 2028
NCT07081503Lead Sponsor
Phase 1 Study of ADX-626 in Healthy Participants
PHASE1Not yet recruiting
44 participants
Started: Jul 14, 2025 · Completed: Jan 22, 2027
NCT06205628Lead Sponsor
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
PHASE1Recruiting
120 participants
Started: Mar 21, 2024 · Completed: Sep 30, 2026
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...